Cerebral autoregulatory performance and the cerebrovascular response to head-of-bed positioning in acute ischaemic stroke by Truijen, J et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Cerebral autoregulatory performance and the cerebrovascular response to head-of-bed
positioning in acute ischaemic stroke
Truijen, J; Rasmussen, L S; Kim, Y S; Stam, J; Stok, W J; Pott, F C; van Lieshout, J J
Published in:






Publisher's PDF, also known as Version of record
Document license:
CC BY-NC
Citation for published version (APA):
Truijen, J., Rasmussen, L. S., Kim, Y. S., Stam, J., Stok, W. J., Pott, F. C., & van Lieshout, J. J. (2018). Cerebral
autoregulatory performance and the cerebrovascular response to head-of-bed positioning in acute ischaemic
stroke. European Journal of Neurology, 25(11), 1365-e117. https://doi.org/10.1111/ene.13737
Download date: 03. Feb. 2020

Cerebral autoregulatory performance and the cerebrovascular
response to head-of-bed positioning in acute ischaemic stroke
J. Truijena,b , L. S. Rasmussenc, Y. S. Kimb,d, J. Stame, W. J. Stokb, F. C. Pottc and J. J. van Lieshoutb,f,g
aDepartment of Internal Medicine, Waterlandziekenhuis, Purmerend; bMedical Biology Laboratory for Cardiovascular Physiology, AMC
Center for Heart Failure Research, Academic Medical Center, University of Amsterdam, Amsterdam,, The Netherlands; cBispebjerg
Hospital Research Unit for Anesthesia and Intensive Care, University of Copenhagen, Copenhagen, Denmark; dDepartment of
Nephrology, VU University Medical Center, Amsterdam; eStroke Unit Department of Neurology, Academic Medical Center, University
of Amsterdam, Amsterdam; fDepartment of Internal Medicine Academic Medical Center, University of Amsterdam, Amsterdam, The
Netherlands; and gMRC/ARUK Centre for Musculoskeletal Ageing Research, School of Life Sciences, The Medical School, Queen’s








Received 4 February 2018
Accepted 19 June 2018
European Journal of
Neurology 2018, 25: 1365–
1371, e116–e117
doi:10.1111/ene.13737
Background and purpose: Cerebrovascular responses to head-of-bed position-
ing in patients with acute ischaemic stroke are heterogeneous, questioning the
applicability of general recommendations on head positioning. Cerebral
autoregulation is impaired to various extents after acute stroke, although it is
unknown whether this aﬀects cerebral perfusion during posture change. We
aimed to elucidate whether the cerebrovascular response to head position
manipulation depends on autoregulatory performance in patients with ischae-
mic stroke.
Methods: The responses of bilateral transcranial Doppler ultrasound-deter-
mined cerebral blood ﬂow velocity (CBFV) and local cerebral blood volume
(CBV), assessed by near-infrared spectroscopy of total hemoglobin tissue con-
centration ([total Hb]), to head-of-bed lowering from 30° to 0° were deter-
mined in 39 patients with acute ischaemic stroke and 17 reference subjects
from two centers. Cerebrovascular autoregulatory performance was expressed
as the phase diﬀerence of the arterial pressure-to-CBFV transfer function.
Results: Following head-of-bed lowering, CBV increased in the reference sub-
jects only ([total Hb]: + 2.1  2.0 vs. + 0.4  2.6 lM; P < 0.05), whereas
CBFV did not change in either group. CBV increased upon head-of-bed low-
ering in the hemispheres of patients with autoregulatory performance <50th
percentile compared with a decrease in the hemispheres of patients with better
autoregulatory performance ([total Hb]: +1.0  1.3 vs. 0.5  1.0 lM;
P < 0.05). The CBV response was inversely related to autoregulatory perfor-
mance (r = 0.68; P < 0.001) in the patients, whereas no such relation was
observed for CBFV.
Conclusion: This study is the ﬁrst to provide evidence that cerebral autoregu-
latory performance in patients with acute ischaemic stroke aﬀects the cere-
brovascular response to changes in the position of the head.
Introduction
Ischaemic stroke results from a serious mismatch
between oxygen demand and delivery due to a sudden
interruption in the blood supply to the aﬀected brain
region. Neurons located in the ischaemic core of the
infarction are generally not eligible for recovery,
whereas neurons in the penumbra have the potential
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to regain function, provided that a sufficient recovery
of blood supply and tissue oxygenation occurs [1].
Cerebral perfusion pressure decreases when the brain
is elevated above heart level [2], which is potentially
of importance for patient positioning and mobilization
after a stroke [3]. However, at group level, a horizon-
tal versus elevated head-of-bed position for the ﬁrst
24 h after stroke does not seem to aﬀect neurological
outcome [4]. On the other hand, the cerebrovascular
eﬀect of head-of-bed positioning in acute ischaemic
stroke is quite heterogeneous, including paradoxical
responses [5–12]. This questions generalized recom-
mendations and suggests that patient-tailored posi-
tioning may be more appropriate.
Cerebral blood ﬂow (CBF) is autoregulated, i.e. it
is maintained more or less constant despite changes in
cerebral perfusion pressure [13]. Acute ischaemic
stroke negatively aﬀects cerebral autoregulatory per-
formance [14–16]. The dependency of cerebral perfu-
sion on head-of-bed position in patients with stroke
has been suggested to reﬂect impaired autoregulation
[5,9,12], but whether autoregulation performance
impacts on the cerebrovascular response to changes in
head-of-bed position has not been substantiated.
We hypothesized that the cerebrovascular response
to head-of-bed manipulation depends on cerebral
autoregulatory performance in acute ischaemic stroke.
We aimed to determine the relationship between cere-
bral autoregulatory performance and the cerebrovas-
cular response determined by transcranial Doppler
(TCD) ultrasonography and near-infrared spec-
troscopy (NIRS) to head-of-bed lowering in patients
with acute ischaemic stroke and in reference subjects.
Methods
Subjects
Consecutive patients admitted to the Stroke Units of
the Academic Medical Centre (Amsterdam, The
Netherlands) and Bispebjerg Hospital (Copenhagen,
Denmark) with an acute onset of non-convulsive focal
neurological deﬁcit were included. Exclusion criteria
were signs of cerebral hemorrhage on computed
tomography scan, arrhythmia, a history of cardiac or
central nervous system disease or inability to provide
informed consent. Stroke severity was quantiﬁed
according to the National Institutes of Health Stroke
Scale. Age-matched volunteers without a history of
cardiac or central nervous system disease served as
reference subjects. Subjects received verbal and written
explanation about the objectives and measurement
techniques associated with the study. Informed con-
sent was provided in accordance with the Helsinki
Declaration. The Medical Ethics committees of the
Academic Medical Centre and Bispebjerg Hospital
approved the study protocol.
Protocol and measurements
Bedside measurements were performed at the stroke
units <48 h after onset of stroke. Reference subjects
were studied ≥2 h after a light meal without caﬀeine-
containing beverages. Instrumentation was performed
with the head-of-bed position elevated to 30°. Subse-
quently, a 5-min baseline measurement in the same
position was followed by 0° head-of-bed position for
5 min. In all patients (n = 39) and reference subjects
(n = 17) continuous blood pressure was measured
(Portapres M2; TNO-BMI, Amsterdam, The Nether-
lands) with the cuﬀ applied to the midphalanx of the
middle ﬁnger of the non-paralytic hand ﬁxed at heart
level and calibrated by oscillometry (M5-I; Omron
Healthcare Inc., Kyoto, Japan). To estimate CBF,
bilateral blood ﬂow velocity was measured by TCD
ultrasonography (Multidop 94; DWL, Singen, Ger-
many) through the temporal acoustic windows in the
proximal segments of the left and right middle cerebral
artery. TCD ultrasonography determines cerebral
blood ﬂow velocity (CBFV) in large cerebral arteries
leaving changes in microvascular and collateral blood
ﬂow undetected. In patients and reference subjects
from Amsterdam, bilateral changes in the cerebral
microcirculation were monitored using continuous-
wave NIRS (Oxymon Mk II; Artinis Medical Systems
BV, Elst, The Netherlands). NIRS tracks microvascu-
lar perfusion by trans-illuminating the cerebral cortex
and detects head-of-bed position-induced changes in
cerebral perfusion not sensed by TCD ultrasonography
[5,6,12,17]. NIRS diﬀerentiates between oxygenated
([oxy-Hb]) and deoxygenated ([deoxy-Hb]) hemoglobin
tissue concentration, with local changes in cerebral
blood volume (CBV) being reﬂected by total hemoglo-
bin tissue concentration ([total Hb]) [18–20]. During
manipulation of CBF, [oxy-Hb] runs in parallel with
the brain capillary oxygen saturation [21] and relates
to the blood-oxygen-level-dependent functional mag-
netic resonance imaging [22–25]. A diﬀerential path
length factor of 6.0 was applied to account for the
scattering of light in the tissue. NIRS signals were
recorded at 10 Hz above the supraorbital ridge and
below the hairline. Changes in cutaneous perfusion
may interfere with the accuracy of cerebral oximetry,
whereas the distance between the transmitter and the
receivers was 5.5 cm to assure sufficiently deep pene-
tration of the near-infrared light into the brain to
exclude substantial contamination from the extracere-
bral circulation [18]. TCD ultrasonography probes and
© 2018 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
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NIRS optodes were secured with a headband (modi-
ﬁed Mark 600; Spencer Technologies, Redmond, WA,
USA). Blood pressure, TCD ultrasonography and
NIRS signals were analog-to-digital converted and
stored for analysis.
Analysis
Changes in [oxy-Hb], [deoxy-Hb] and [total Hb] were
expressed relative to baseline (30° head-of-bed posi-
tion). Mean arterial pressure (MAP) and CBFV were
the integral over one heartbeat. Heart rate was taken
from the pressure pulse interval. MAPbrain accounted
for the hydrostatic diﬀerence between the level of the
heart and the TCD ultrasonography probe at 30°
head-of-bed elevation. Cardiac stroke volume was
determined by pulse wave analysis (BeatScope 1.0
software; BMEYE, Amsterdam, The Netherlands)
and cardiac output was cardiac stroke volume 9 heart
rate.
Cerebral autoregulatory performance in dampening
the transfer of ﬂuctuations in arterial pressure to
CBFV can be represented by the latency between the
input (arterial pressure) and output (CBFV) signals.
To that purpose, cerebral autoregulatory performance
was assessed in the frequency domain in order to
determine the phase diﬀerence (Φ) between MAP and
CBFV, where lower Φ implies more passive following
of CBFV to ﬂuctuations in arterial pressure and
hence reduced cerebral autoregulatory performance
[14,15,26]. A 4-min tracing of beat-to-beat data of
MAP and CBFV was spline interpolated and resam-
pled at 4 Hz. To quantify the variability of MAP
and CBFV, their power spectra were determined by
transforming the MAP and CBFV time series with
discrete Fourier transformation to the frequency
domain. Transfer function phase diﬀerence (Φ) and
gain were derived from the cross spectrum.
According to the high-pass ﬁlter model of cerebral
autoregulation (CA) performance, performance of
autoregulation is reﬂected by the Φ between oscilla-
tions of MAP (input function) and CBFV (output
function) [27,28]. Results were expressed as the aver-
aged integrated area for the low (0.07–0.15-Hz) fre-
quency range. The transfer function gain was
normalized for MAP and CBFV and expressed as
the percentage change in CBFV per percent change
in MAP to account for intersubject variability
[14,15]. To examine the strength of the relationship
between MAP and CBFV, coherence was used to
express the degree to which the two signals co-vary
signiﬁcantly. Coherence above 0.5 was considered to
provide a reliable estimate of the transfer function
variables [28].
Diﬀerences between hemispheres and between head-
of-bed positions were examined by two-way ANOVA
for repeated measurements. Comparison between
hemispheres with high versus low cerebral autoregula-
tory performance was performed after dichotomizing
data according to the median Φ for each group. Dif-
ferences between patients and reference subjects were
identiﬁed by T-test when data ﬁt a normal distribu-
tion; otherwise, Mann–Whitney U-test was used. Data
of the left and right hemispheres in the reference sub-
jects were averaged. Correlation between the cere-
brovascular responses to head-of-bed lowering and
cerebral autoregulatory performance was evaluated by
univariate linear regression analysis. Data are pre-
sented as mean  SD unless otherwise indicated.
P < 0.05 was considered to indicate statistical signiﬁ-
cance.
Results
A total of 39 patients with acute ischaemic stroke met
the inclusion criteria and 17 healthy volunteers served
as reference subjects (Table 1). Figure 1 summarizes
patient eligibility and inclusion according to data
quality and availability. All recordings from the refer-
ence subjects fulﬁlled the required signal quality for
analysis; MAP–CBFV coherence was insufficient for
determination of cerebral autoregulatory performance
in one patient hemisphere.
Table 1 Demographics of patients and reference subjects
Patients with stroke Reference subjects
Male/female 20/19 7/10
Age (years) 68  12 64  7
Weight (kg) 75  15 72  11
Height (cm) 173  9 169  8
BMI 25  4 26  4
Stroke side (R/L) 20/19 N/A
NIHSS score 8  6 N/A
History
Hypertension 11 2










Glucose-lowering drug 2 0
Data are given as mean  SD. ACE, angiotensin-converting
enzyme; AT2RA, angiotensin type 2 receptor antagonist; BMI, body
mass index; L, left; N/A, not applicable; NIHSS, National Institutes
of Health Stroke Scale; R, right.
© 2018 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
HEAD POSITION AND AUTOREGULATION IN STROKE 1367
Cerebrovascular autoregulation and cerebrovascular
responses to head-of-bed lowering
Autoregulatory performance was not signiﬁcantly dif-
ferent between groups or hemispheres (Table 2). In
response to head-of-bed lowering, local CBV, reﬂected
by NIRS-determined [total Hb], increased in the hemi-
spheres of patients with autoregulatory performance
<50th percentile (Φ < 37°), whereas it tended to
decrease in the hemispheres of patients with better
autoregulatory performance (Fig. 2). The local CBV
responses to head-of-bed lowering related inversely to
Φ in the patients (P < 0.05) (Fig. 3), whereas no such
relationship was found in the reference subjects
(Fig. 3). In both groups, the TCD ultrasonography
determined that CBFV response to head-of-bed lower-
ing did not relate to autoregulatory performance.
Cardiovascular and cerebrovascular responses to
head-of-bed lowering
At baseline with the head-of-bed position elevated at
30°, MAP, heart rate and cardiac output were higher
in the patients, whereas CBFV was similar in patients
and reference subjects (Fig. 4). In both groups, head-
of-bed lowering increased MAPbrain and cardiac out-
put but not CBFV. Local CBV increased in the
reference subjects only, mainly as a result of an
increase in [oxy-Hb], whereas changes in the patients
were non-signiﬁcant at group level (Fig. 4).
Figure 1 Inclusion and assessment of
near-infrared spectroscopy (NIRS) and
transcranial Doppler (TCD) ultrasonog-
raphy in ipsilateral and contralateral
hemispheres in patients with stroke.
© 2018 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
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Discussion
The cerebrovascular response to head-of-bed position-
ing in acute ischaemic stroke varies widely across
patients [5–12]. In the present study, we reveal that, in
patients with acute ischaemic stroke, the cerebrovascu-
lar response to a change in head position relates to
cerebral autoregulatory performance. This is of clini-
cal relevance considering the potential inﬂuence of
positioning and mobilization on clinical outcome in
ischaemic stroke [3]. The data suggest that cerebral
autoregulatory performance is to be accounted for
when considering patient head positioning and mobi-
lization.
Transcranial Doppler ultrasonography tracks blood
ﬂow velocity in large vessels and constancy of the
insonated vessel diameter, as assessed with ultra-high-
ﬁeld magnetic resonance imaging, links velocity to
ﬂow [29], rather than reﬂecting collateral perfusion in
patients with cerebrovascular disease [5]. Within the
cortical volume sampled by NIRS, hemoglobin is con-
tained in arterioles, capillaries and venules, whereas
the relative arterial and venous contributions vary [30]
and changes in [total Hb] correspond to CBV deter-
mined by positron emission tomography [19,20]. Com-
bining TCD ultrasonography and NIRS provides
insight into the perfusion changes in both large and
small cerebral blood vessels, including collateral circu-
lation [5,6]. The requirement for adequate signal qual-
ity together with sufficient transfer function coherence
limited the number of observations in which we were
able to relate the cerebrovascular to the cerebral
autoregulatory performance. In particular, obtaining






6.3  3.8a 3.8  2.9
CBFV power[(cm/s)2/Hz] 3.1  2.8 4.6  8.6 2.5  2.3
MAP–CBFV transfer function
Φ (°) 43  18 48  21 42  11
Normalized gain (%/%) 0.37  0.20 0.47  0.49 0.53  0.31
Coherence (k2) 0.71  0.13 0.69  0.15 0.74  0.09
Data are given as mean  SD. Φ, phase diﬀerence; CBFV, cerebral
blood ﬂow velocity; MAP, mean arterial pressure. aP < 0.01 vs. ref-
erence group.
Figure 2 Changes in cerebral blood volume, expressed as cere-
bral total hemoglobin tissue concentration (D[total Hb]), after
head-of-bed lowering in hemispheres with cerebral autoregula-
tion (CA) performance <50th percentile vs. >50th percentile
(Φ = 37°) in patients with acute stroke ( ) and reference sub-
jects (□). Boxes indicate median, 25th and 75th percentile, error
bars indicate 10th and 90th percentile. CTRL, control.
*P < 0.05 vs. lower CA performance.
Figure 3 Relation between cerebral autoregulation (CA) perfor-
mance and the change in cerebral total hemoglobin tissue con-
centration [total Hb] after head-of-bed lowering in patients with
stroke (a) (▲, aﬀected hemispheres; ○, non-aﬀected hemi-
spheres) and reference subjects (b) (●, left hemispheres; , right
hemispheres).
© 2018 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
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good-quality TCD ultrasonography data can be chal-
lenging, illustrated by a study in more than 3000
(healthy) subjects where bilateral TCD ultrasonogra-
phy signals were available in <50% of subjects [31].
Nevertheless, the present study is the ﬁrst to demon-
strate a relation between cerebral autoregulatory per-
formance and the cerebrovascular response to head
positioning in acute ischaemic stroke.
Initial observations in patients with severe ischaemic
stroke suggested CBF as being maximal in the hori-
zontal head-of-bed position [9,10], but this was not
unanimously conﬁrmed in more recent studies in mild
to moderate stroke [5–7]. Considerable heterogeneity
in responses has been observed ranging from an
increase to indiﬀerent or paradoxical reactions that
could not be explained by clinical or radiological
patient features [5–8,11]. Our ﬁndings are not
intended to support either the horizontal or elevated
head-of-bed position as it remains uncertain how these
physiological eﬀects translate into clinical outcome.
Recently, the lying-ﬂat position versus the sitting-up
position for the ﬁrst 24 h after stroke did not aﬀect
neurological outcome at group level [4]. However,
very early mobilization versus standard care in
patients with stroke resulted in a less favorable out-
come [3], whereas the role of cerebral perfusion in this
outcome is as yet unknown.
Fundamentally, CA is an abstract entity rather than
a physical quantity [28], with autoregulatory perfor-
mance as a continuum of stages rather than an ‘all-or-
nothing’ phenomenon. Cerebral autoregulatory
performance is highly variable among both patients
and healthy subjects [14–16] and clear cut-oﬀ criteria
on ‘normal’ versus ‘impaired’ autoregulation are as
yet lacking [26]. CA counter-regulates an increase in
cerebral perfusion pressure by means of cerebral vaso-
constriction reducing CBV [32]. However, cerebral
hypoperfusion and ischaemia induce compensatory
Figure 4 Cardiovascular and cerebrovascular variables during head-of-bed position lowering in patients (■) [ipsilateral (♦) and con-
tralateral ● hemispheres] and control subjects (□). D[total Hb], change in total hemoglobin tissue concentration; D[oxy-Hb], change in
oxygenated hemoglobin tissue concentration; D[deoxy-Hb], change in deoxygenated hemoglobin tissue concentration; CBFV, cerebral
blood ﬂow velocity; CO, cardiac output; HR, heart rate; MAP, mean arterial pressure. Near-infrared spectroscopy data are relative
changes to 30°. *P < 0.05 vs. control; #P < 0.05 vs. 30°. Data are mean  standard error.
© 2018 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
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cerebrovascular vasodilatation until autoregulatory
capacity becomes exhausted with increased CBV [33].
Local increases in CBV induce pressure diﬀerentials
potentially provoking brain tissue shifts and neuro-
logic deterioration [34]. Less eﬀective CA in ischaemic
stroke is associated with an increased risk of cerebral
edema and hemorrhagic transformation [33–35] and
worse clinical outcome [36]. The ideal head-of-bed
position after ischaemic stroke is to be balanced
between optimal cerebral perfusion and minimal risk
for cerebral edema, reperfusion injury, hemorrhagic
transformation or respiratory complications [37].
Postural changes in cerebral perfusion are com-
monly considered to reﬂect impairment of CA in
patients with stroke. However, in healthy humans,
positional changes in cerebral perfusion are physiolog-
ical with a ~15% postural reduction in CBV and ~8%
postural reduction in cerebral cortical oxygenation
[6,38–40]. Together with Aries et al. [6], the present
study is one of few that included a reference group
without manifest cerebrovascular disease. Although
the average cerebral autoregulatory performance did
not diﬀer between the two groups, the increase in
CBV with head-of-bed lowering in the reference sub-
jects was larger and not related to cerebral autoregula-
tory performance. Aries et al. observed a similar trend
toward larger cerebrovascular changes in healthy
controls versus patients with stroke [6]. We may spec-
ulate that, according to the Monro–Kellie doctrine
[41], CBV after ischaemic stroke could be less respon-
sive to postural changes as cerebral edema and
increased intracranial pressure avert the inﬂow of
extra blood volume.
Conclusion
Our study provides evidence that, in patients with
acute ischaemic stroke, cerebral autoregulatory perfor-
mance aﬀects the cerebrovascular response to changes
in the position of the head. The ﬁndings suggest that
patients could beneﬁt from individualized positioning
and mobilization and question the feasibility of gener-
alized recommendations on this issue.
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